Dihydrolipoamide

From NuGOwiki

(Redirected from HMDB00985)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Dihydrolipoamide
File:HMDB00985.png
2D structure for Dihydrolipoamide
Chemical Name 6,8-bis-sulfanyloctanamide
Chemical Formula C8H17NOS2
CAS Number 3884-47-7
Chemical Information HMDB00985
Biochemical Taxonomy

  • Lipoamides and Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Alanine and Aspartate Metabolism
  • Citrate Cycle
  • Pyruvate Metabolism
  • Valine, Leucine and Isoleucine Degradation

Biofluid Location Not Available
Tissue Location Not Available
Normal Biofluid Concentrations Not Available
Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition Not Available
Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations Not Available
Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Dihydrolipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG ID C00579). It is converted to lipoamide via the enzyme dihydrolipoamide dehydrogenase [EC:1.8.1.4]. Dihydrolipoamide is also a substrate of enzyme Acyltransferases [EC 2.3.1.-]. (KEGG)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines


Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines